If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Serenella Servidei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Mitochondrial Diseases Medicine & Life Sciences
Mutation Medicine & Life Sciences
Limb-Girdle Muscular Dystrophies Medicine & Life Sciences
Glycogen Storage Disease Type II Medicine & Life Sciences
Lipomatosis Medicine & Life Sciences
Enzyme Replacement Therapy Medicine & Life Sciences
Lipoma Medicine & Life Sciences
Hereditary Spastic Paraplegia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2020

Awareness of rare and genetic neurological diseases among italian neurologist. A national survey

Mancuso, M., Filosto, M., Lamperti, C., Musumeci, O., Santorelli, F. M., Servidei, S., Valente, E. M., Zeviani, M., Mancardi, G., Tedeschi, G. & Federico, A., Jan 1 2020, (Accepted/In press) In : Neurological Sciences.

Research output: Contribution to journalArticle

Inborn Genetic Diseases
Rare Diseases
Neurology
Nervous System Diseases
Neurologists

Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group

Filosto, M., Cotti Piccinelli, S., Ravaglia, S., Servidei, S., Moggio, M., Musumeci, O., Donati, M. A., Pegoraro, E., Di Muzio, A., Maggi, L., Tonin, P., Marrosu, G., Sancricca, C., Lerario, A., Sacchini, M., Semplicini, C., Bozzoni, V., Telese, R., Bonanno, S., Piras, R. & 10 others, Maioli, M. A., Ricci, G., Vercelli, L., Galvagni, A., Gallo Cassarino, S., Caria, F., Mongini, T., Siciliano, G., Padovani, A. & Toscano, A., May 2019, In : Advances in Therapy. 36, 5, p. 1177-1189 13 p.

Research output: Contribution to journalArticle

Glycogen Storage Disease Type II
Enzyme Replacement Therapy
Antibodies
Late Onset Disorders
Vital Capacity

Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group

Filosto, M., Cotti Piccinelli, S., Ravaglia, S., Servidei, S., Moggio, M., Musumeci, O., Donati, M. A., Pegoraro, E., Di Muzio, A., Maggi, L., Tonin, P., Marrosu, G., Sancricca, C., Lerario, A., Sacchini, M., Semplicini, C., Bozzoni, V., Telese, R., Bonanno, S., Piras, R. & 10 others, Maioli, M. A., Ricci, G., Vercelli, L., Galvagni, A., Gallo Cassarino, S., Caria, F., Mongini, T., Siciliano, G., Padovani, A. & Toscano, A., Jan 1 2019, In : Advances in Therapy. 36, 5, p. 1177-1189

Research output: Contribution to journalArticle

Glycogen Storage Disease Type II
Enzyme Replacement Therapy
Antibodies
Late Onset Disorders
Vital Capacity
Hereditary Spastic Paraplegia
Mutation
Brain
Magnetic Resonance Imaging
Phenotype